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Abstract—Stochastic Petri Nets (SPN) are recognized as one of
the standard formalisms to model metabolic networks. They allow
incorporating randomness in the model and taking into account
possible fluctuations and noise due to molecule interactions in the
environment. Even though some frameworks have been proposed
to implement and simulate SPN (e.g., Snoopy, Monalisa), they
do not allow for automatic model parameterization, which is
a crucial task to identify the network configurations that lead
the model to satisfy certain biological properties. We present a
framework to synthesize the SPN model of a metabolic network
into executable code that can be simulated through a discrete
event-based simulator. The framework allows the user to formally
define the network properties to be observed and to automatically
extrapolate, through Assertion-based Verification (ABV), the
parameter configurations that lead the network to satisfy such
properties. We applied the framework to model the purine
metabolism and to reproduce the metabolomics data obtained
from naive lymphocytes and autoreactive T cells implicated
in the induction of experimental autoimmune disorders. We
show system parameterization extrapolated by the framework
to reproduce the experimental results and to simulate the model
under different conditions.
Index Terms—Stochastic Petri Net, Metabolic Networks, Elec-
tronic Design Automation, T cells, Autoimmunity.
INTRODUCTION
Petri nets (PN) are an effective formalism used to model
metabolic networks. PN have been widely applied in Sys-
tems Biology because they provide an intuitive graphical
representation, well-founded mathematical properties (e.g.,
place/transition invariants) for qualitative analysis, and exten-
sions to perform dynamic system simulation. Place invariants
(p-invariants) and transition invariants (t-invariants) were used,
for example, to validate important biological processes such
as apoptosis [1] and to understand the processes at the basis
of the iron homeostasis [2].
PNs have been also adopted to perform quantitative analysis
of biological systems. In particular, stochastic Petri nets (SPN)
have gained popularity in Systems Biology because, unlike
ordinary differential equations (ODEs), they support the inher-
ent uncertainty of the biological processes [3]. For example,
SPN have been succefully used to obtain new insights in the
development of hepatic granuloma throughout the course of
infection [4], and to model signal transduction pathways in
the process of angiogenesis [5].
Software applications have been developed to model and
simulate biological systems through SPN. The best known
are Snoopy [6] and Monalisa [7]. They allow simulating
complex biochemical systems including metabolic pathways,
signal transduction pathways, and gene expression networks.
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A recurrent issue of these software applications is related
to the concept of parameterization. Very often, due to the
lack of quantitative information, it is necessary to explore the
solution space of the parameters to identify which network
configurations lead the model to satisfy certain biological
properties. This process requires the manual tuning of un-
known parameters to obtain model behaviors matching the
biological knowledge. Since the solution space to explore
grows exponentially with the network size, such a manual
parametrization task becomes prohibitive when applied to real-
istically large networks. In this work we propose a framework
that applies languages, techniques, and tools well established
in the field of electronic design automation (EDA) to model
and simulate metabolic networks. Since biological systems and
electronics systems share several characteristics like concur-
rency, reactivity, abstraction levels as well as issues like reverse
engineering and design space exploration [8], we show how
the proposed EDA-based framework can introduce automation
and flexibility to model, simulate, and to help the analysis
of metabolic networks. EDA techniques have been applied to
study qualitatively the leukocyte integrin-activation signalling
network through the use of boolean networks [9]. However,
the study of metabolic networks dynamics requires to take into
account the flux of metabolites in a quantitative way. In this
paper we present a new framework that, starting from a PN
model of a metabolic network, generates executable code that
implements SPN to simulate the network dynamics suitable
for discrete event-based simulation. The user defines network
properties through a formal specification language, which
are synthesized and integrated into the network code. The
framework then applies Assertion-based Verification (ABV)
combined to an automatic parameter generation based on a
genetic algorithm to extrapolate the parameter configurations
that satisfy the defined network properties.
We applied the framework to model and simulate the purine
metabolism and to reproduce the metabolomics data obtained
from naive lymphocytes and autoreactive T cells implicated
in the induction of experimental autoimmune disorders. We
show that the framework automatically extrapolates system
parametrizations that reproduce the experimental results and
that allow simulating the model under different conditions.
I. BACKGROUND ON STOCHASTIC PETRI NETS
SPN is a class of Petri nets in which at every transition
k of the network state is associated a delay τk, which is
determined by a random variable. Formally, a SPN is a five-
tuple SPN = {P, T, F,M0,Λ} where P is the set of the
places, T the set of transitions, F ⊂ (P × T ) ∪ (T × P )
is the set of relations between places and transitions, M0 is
the initial configuration of the net (marking), and Λ is the
set of exponentially distributed firing rates λk associated with
the transitions. The firing rates are defined trough propensity
functions (hazard) ak that have the pre-places of the transition
k as domain, and it gives the probability that a reaction will
occur in the next infinitesimal time interval.
To simulate biochemical systems, specific types of propen-
sity functions are used, such as mass-action propensity func-
tions and Michelis-Menten propensity functions. A well-
established method to perform a simulation of a SPN is the
Gillespie’s algorithm, called Stochastic Simulation Algorithm
(SSA). This method is a Monte Carlo procedure that calculates
a possible trajectory of the system simulating one chemical
reaction at each step, and that chooses the firing time τ .
Gillespie proposed two equivalent variants of his algorithm:
the Direct Method (DM) [10], and the First Reaction Method
(FRM) [11]. In general, DM is more efficient in terms of
computational time and space while FRM is well suited for a
concurrent and parallel implementation [12]. Our methodology
is based on the FRM variant.
II. METHODS
A. Discrete Event-based Simulation of Stochastic Petri Nets
through an EDA Framework
The proposed methodology simulates the system under anal-
ysis through SPN. Our methodology implements an adapted
version of the FRM algorithm in which the reaction delay τrk











+ 1 (k = 1, . . . ,m)
where r1, . . . , rm are m random numbers from the uniform
distribution U(0, 1), ak(mi) = cimi is the mass-action
propensity function where ci is the reaction rate and mi
the number of tokens of the reactant. We consider a lower-
bound value of the delay (i.e., 1), which is associated to
the minimum delay in the discrete event-based simulation.
The system starts by assigning a delay τrk to each reaction.
At each simulation step, the system executes the reactions
with the minimum delay and updates the simulation time
and the propensity functions of the reactions involved in the
execution. To perform the event-driven simulation of the SPN,
we propose a methodology to implement SPNs through the
Extended Finite State Machines (EFSMs) [13], which allow
the network to be synthesized into executable SystemC code.
SystemC [14] is the reference language in EDA to model
and simulate complex systems at different abstraction levels.
SystemC-based verification is the de-facto alternative to model
checking when such a formal verification technique cannot
deal with the state space complexity of the model.
Fig. 1(a) shows two basic reactions and their representation
through Petri net models.
Fig. 1(b) shows, as a representative example, how the
reactions related to the metabolite Mj of the top left example
are represented by EFSMs. The activity of a metabolite is
defined by its production and consumption behaviour. The
production and consumption processes are represented by two
concurrent EFSMs, each one based on a two-state machine.
In the Mi-Mj reaction, when the consumption process of the
preplace Mi is in the ready state or its concentration (mi)














































































Fig. 1. Examples of basic reactions and their mapping in EFSM and
SystemC models: (a) the Petri net models of the reactions, (b) the
EFSM representation of the reactions related to Mj , (c) the SystemC
template implementing Mj .
sent to Mj and its state changes to wait. The production
process of Mj wakes up by receiving mi and, if the reaction is
feasible, the model calculates the reaction delay τr1 and saves
the current simulation instant (t r1start). Variable t represents
the simulated time, and is updated by the SystemC simulation
kernel at each simulation step. The transition leads the machine
into the wait state, which implements the stochastic reaction
delay based on mass-action law. The model blocks the process
to the wait state until the reaction delay expires. However,
during the waiting time, Mj may have to update τr1 and
t r1start due to a change in the concentration of the pre-place
Mi. When the reaction is performed, the machine moves to the
ready state, by increasing the Mj concentration by mul(r1)
and sending a notify to the Mi consumption process. Thus,
the Mi consumption process decreases mi and returns to the
ready state.
Fig. 1(c) shows the SystemC implementation of the starting
SPN, which can be automatically synthesized by the corre-
sponding EFSM model.
B. Parameter estimation through Assertion-based verification
(ABV)
In EDA, functional verification based on assertions repre-
sents one of the main applied and investigated techniques that
combines simulation-based (i.e., dynamic) and formal (i.e.,
static) verification [15], [16]. Assertions are formal descrip-
tions that allow system designers to detect functional errors
in the model and in the model evolution over time. They
are also combined to techniques of automatic input pattern
generation [17] that extrapolate system configurations to prove
the satisfiability or unsatisfiability of the system properties.


















Fig. 2. Petri net model of the purine pathway.
which assertions are defined in PSL language [18], they are
automatically synthesized into checkers [19], and plugged to
the SystemC model representing the network. In our context,
checkers aim at monitoring the concentration of the metabo-
lites and to give a score (i.e., fitness) to an input generation
module, which implements a genetic algorithm to generate
good configurations of the kinetic parameters. The module
generates a configuration of parameters and runs a dynamic
simulation of the network for such a set of input values for
a given simulation time. Then, the module generates a new
different configuration for a new simulation. A proper fitness
function evaluates the goodness of each potential solution
estimated through simulation. The run ends when the mod-
ule finds the parameter configuration that allows the system
properties to be satisfied. The definition of the fitness function
depends on the property to check and it is formulated as
the distance between state vectors representing the simulation
trend si(t) in comparison to a defined reference trend ri(t)
(i.e., the target behaviour of the system). The ABV checks the
simulation trend si(t) and, eventually, it stops the simulation
to provide a score compared to ri(t). Given the state vectors
S = [s1, s2, . . . , sn] and R = [r1, r2, . . . , rn] representing,
respectively, the simulation and the reference trend, the score
is defined as follow:
scorec(t) = d(S,R)
where d is a distance function (e.g., Euclidean distance). The
score of each found parameterization can be used to prioritize
configurations selecting those that are closest to the reference
trend.
III. RESULTS AND DISCUSSION
We applied our methodology to understand how the dy-
namics of the purine pathway changes between normal and
autoreactive conditions. The relative concentrations of the
metabolites were determined from metabolomics analysis
(http://www.metabolon.com/) in lysates from naive lympho-
cytes and actively proliferating PLP-specific T cells [20].
The purine pathway was summarized in our Petri net model
starting from PRPP transformation to IMP and ending to the
production of dAMP, dGMP and urate as waste products
of purine synthesis and catabolism (Fig.2). We multiplied
the relative concentration of each metabolite by a factor of
103 to obtain an integer number of tokens. Due to the lack


































Fig. 3. Example of parameterization of the purine pathway in PLP-
specific condition that lead the metabolites to stability within a
simulation time of 105 clock cycles. At the top, the PSL assertion
used to check stability.
of experimental data for PRPP, we assigned to it the same
concentration of IMP. Here with the term concentration we
refer to the number of tokens of a metabolite. We simulated
our model generating reaction delays in the range [1−1000] of
all network reactions, which keep stable the concentrations of
each metabolite (i.e., steady state) except dAMP, dGMP and
urate (Fig.3). We assumed that the pathway is considered at
steady state if the concentration of each element does not differ
by more than σ, set to a ±50% from the initial concentration,
and it is maintained stable throughout a simulation time of 105
simulation cycles. We specified this property formally through
ABV. (Fig. 3) In our model the inhibition mechanisms are
represented through the inhibition arcs, which is an extension
of the classical Petri nets to represent the inhibition of a
molecule when its concentration exceeds a certain threshold.
We assumed that a metabolite can inhibit a reaction when it
grows up by 30% from its initial concentration. Thresholds for
steady state and inhibition were chosen empirically by tuning
the system to obtain the stability of all network metabolites.
The genetic algorithm used by the automatic input generator
has been configured with a population of 250 individuals, a
mutation probability of 0.05 and a crossover probability of
0.1. We defined the reference trend of the system as follows:
ri(t) = mi,∀t > 0, i = 1, 2, ..., n
where mi is the starting concentration of a metabolite and
t is the simulation time. The state vector of the simulation
trend was defined as S = [c1, c2, . . . , cn], where the terms
ci are the set of angular coefficients of the linear functions
si(t), linking the starting and the final concentrations of the
metabolites. The state vector of the reference trend was defined
as R = [0, 0, . . . , 0]. The fitness function was defined as
the inverse of the Euclidean distance between the simulation
trend and the reference trend. The selection method used is
rank-based, taking always individuals with the best fitness for
reproduction.
We obtained 10 parameterizations of the purine pathway for
each condition. Times for the found parameterizations were
on average 9.46 minutes for the network in naive condition
and 7.49 minutes for the PLP-specific. Our simulations led to












































































































































Fig. 4. Results of the analysis of 10 parameterizations of the purine
pathway in condition of stability for naive and PLP-specific cells.
(a) Average difference of the delays obtained parameterizing the
pathway in naive and PLP-specific condition. (b) Difference in the
final concentration of the metabolites dAMP, dGMP and urate.
suggesting that most of chemical reactions are highly favored
in PLP-specific cells versus naive lymphocytes (Fig. 4(a)). In
fact, all metabolic reactions, with the exception of the reactions
from Guanine to Xanthine (Guani:Xa) and from Adenosine to
Inosine (Adeno:Ino), are speeded up in PLP-specific condition,
having a lower average delay time (Fig. 4(a)). Overall, the
observed speed-up in the PLP-specific condition resulted in a
greater production of the fundamental elements of the pathway
dAMP, dGMP and urate (Fig. 4(b)). Notably, the increased
urate, dGMP and dAMP production in PLP-specific network
reflects our metabolomics data and a well-known metabolic
feature of proliferating lymphocytes [21], validating the poten-
tiality of our methodology in simulating metabolic processes.
Improvements of the methodology concern the refinement
of the fitness function to speed-up the convergence of the
genetic algorithm, the implementation of a module for the
robustness/sensitivity analysis of the system and the test of
our methodology on more complex Petri net models.
IV. CONCLUSION
This paper presented a methodology to apply languages,
techniques, and tools well established in the field of EDA
to simulate and automatically parametrize the SPN model of
metabolic networks. We applied the methodology to study
the purine metabolism pathway starting from metabolomics
data obtained from naive lymphocytes and autoreactive T
cells implicated in the induction of experimental autoimmune
disorders. Thanks to the model parametrization automatically
performed by the proposed framework, we were able to
simulate the system under different conditions. The simulation
results suggest that the entire purine pathway is speeded-up in
PLP-specific cells versus naive lymphocytes, according to our
experimental data and literature.
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[17] M. Boulé and Z. Zilic, Generating hardware assertion checkers: for
hardware verification, emulation, post-fabrication debugging and on-
line monitoring. A: Springer, 2008.
[18] IEEE, “Property specification language - psl,” 2017,
https://standards.ieee.org/findstds/standard/1850-2010.html.
[19] Y. Abarbanel et al., “Focs–automatic generation of simulation checkers
from formal specifications,” in Computer Aided Verification. Springer,
2000, pp. 538–542.
[20] L. Piccio, B. Rossi, E. Scarpini, C. Laudanna, C. Giagulli, A. C. Issekutz,
D. Vestweber, E. C. Butcher, and G. Constantin, “Molecular mechanisms
involved in lymphocyte recruitment in inflamed brain microvessels:
critical roles for p-selectin glycoprotein ligand-1 and heterotrimeric gi-
linked receptors,” The Journal of Immunology, vol. 168, no. 4, pp. 1940–
1949, 2002.
[21] T. Eleftheriadis, G. Pissas, A. Karioti, G. Antoniadi, S. Golfinopoulos,
V. Liakopoulos, A. Mamara, M. Speletas, G. Koukoulis, and I. Ste-
fanidis, “Uric acid induces caspase-1 activation, il-1β secretion and
p2x7 receptor dependent proliferation in primary human lymphocytes,”
Hippokratia, vol. 17, no. 2, p. 141, 2013.
